The biotechnology sector is critical for pushing innovation. Whether it’s for health, agriculture, or the environment, scientific advancement can have a profoundly positive impact.
These advancements are made possible through intensive research and development (R&D) efforts, which are typically risky, experimental, and very expensive.Â
To help fuel innovation in the United States, R&D tax credits are a vital tool in offsetting some of these costs. Let’s delve deeper into the subject to understand how R&D tax credits contribute to biotech innovation in the US.
Established under the Economic Recovery Tax Act of 1981, these credits aim to stimulate economic growth by encouraging innovation and technological advancement without worrying about escalating costs.Â
Qualifying activities typically include developing new products, processes, formulas, or technologies, and improving existing ones. Eligible expenses cover wages for R&D personnel, tangible supplies or materials used to conduct research, and US contractor costs who are performing development activities.
U.S. R&D tax credits allow biotechs to offset their tax liability with the R&D credit, thereby reducing their overall tax burden.Â
The federal R&D tax credit can be used in the following ways.Â
Additionally, many states offer their own R&D tax credits, which can be combined with federal credits to further enhance the overall financial benefit.
Often, it can be challenging to understand how to claim tax credits available to your business. However, hiring an accountant with experience in the biotech sector will enable you to make the right choice for your organization.
The list of eligible activities in R&D is long and extensive. Here are some broad examples:
If we break these areas down even further, the claimable expenses fall into the following categories:
Since R&D tax credits provide financial relief, additional resources are freed up which allows you to pump more investment into your R&D programs.
Having an improved cash flow can often accelerate the development of innovations. This is especially true for smaller biotechs which typically operate with limited capital. Often, for these organizations, the tax credits provide an essential source of income until additional funding can be acquired.
At Finvisor, our team of qualified experts will help you understand and navigate the complexities around claiming R&D tax credits. We welcome you to get in touch to learn more.
*This blog does not constitute solicitation or provision of legal advice and does not establish an attorney-client relationship. This blog should not be used as a substitute for obtaining legal advice from an attorney licensed or authorized to practice in your jurisdiction.*
Finvisor HQ
48 2nd Street, 4th Floor
San Francisco, CA 94105
"*" indicates required fields